ForumIAS LATEST
- SFG FRC 2027 | Program starts from 19th Dec. 2026 | Admissions open for Entrance Test Click Here to know more →
- Prelims Test Series (PTS) for Prelims 2027 starts 11th Oct. 2026 Click Here to know more →
- [Pre-order] Ethics Redbook 3rd Edition: Delivery starts from 10th October onwards Click Here to Read More →
- 21 Sept. | GS Advance Program (GSAP) for UPSC 2027 Mains starts from 11th Oct. Click Here to Read More →
- India has decided to send a high-level delegation to China under the India-China Strategic Economic Dialogue(SED) Mechanism.The meeting is scheduled to be held in Beijing in May 2019
- This meeting comes in the backdrop of increasing efforts by India to increase pharmaceuticals exports to China.India has been requesting China to make the drug registration process easier for Indian pharma companies.
- In 2018-19,China figured in the 17th spot in the list of India’s top pharma export destinations.However,the growth potential with China is much higher considering the fact that the exports has grown by 52% in 2017-18.
- The working group meeting will be followed by the Indian delegation visiting Active Pharmaceutical Ingredient (API) plants and interacting with API manufacturers and trade associations.
- Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs.The active ingredient(AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.



